Question 1

What is Ranitidine?

Accepted Answer

Ranitidine belongs to a class of drugs called histamine-2 blockers. It functions by reducing the volume of acid generated by the lining of the stomach.

By decreasing gastric acid levels, the medication helps maintain a more balanced environment within the digestive tract. It works by blocking specific receptors that trigger the release of acid into the stomach.

Question 2

What is Ranitidine used for?

Accepted Answer

Ranitidine is used to treat the reduction of stomach acid in:

Gastroesophageal reflux disease

Peptic ulcer disease

(FDA approval withdrawn).

Question 3

How does Ranitidine work?

Accepted Answer

Mechanism of Action

Ranitidine belongs to a group of medicines called histamine-2 (H2) blockers. It works by targeting specific receptors, called H2 receptors, located on the cells in the lining of the stomach.

Blocking Acid Production

Under normal conditions, a natural chemical in the body called histamine attaches to these H2 receptors. This action signals the stomach to release acid to help digest food. Ranitidine works by competing with histamine for these receptor sites. When ranitidine occupies the receptors, it prevents histamine from binding to them, which effectively blocks the signal to produce acid.

Effects on the Body

By lowering the volume and concentration of stomach acid, ranitidine helps to:

Relieve symptoms: It reduces the burning sensation associated with heartburn and acid indigestion.

Promote healing: Lower acid levels allow the lining of the esophagus and stomach to recover from irritation or damage caused by acid reflux.

Treat and prevent ulcers: It provides an environment that allows stomach or intestinal ulcers to heal and can help prevent them from returning.

Ranitidine starts to work shortly after it is taken to decrease the production of new acid. However, it does not neutralize the acid that is already present in the stomach, which is how liquid or chewable antacids typically function.

Question 4

What are the brand names for Ranitidine?

Accepted Answer

Ranitidine is sold under the brand names Zantac and Ranitidine .

Question 5

What are the active ingredients in Ranitidine?

Accepted Answer

The active ingredient in Ranitidine is ranitidine .

Question 6

What are the side effects of Ranitidine?

Accepted Answer

Common side effects of Ranitidine may include:

headache

constipation

diarrhea

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Ranitidine?

Accepted Answer

Ranitidine belongs to the H2 receptor antagonist drug class.

Question 8

What is the dosage of Ranitidine and how do I take it?

Accepted Answer

Administration and Frequency

Ranitidine was available as a tablet, capsule, or liquid syrup to be taken by mouth. It was also administered by healthcare professionals as an injection into a muscle or a vein. Depending on the condition, it was usually taken once or twice daily, though some conditions required more frequent dosing.

For the prevention of heartburn, the medication was typically taken shortly before eating or drinking things that might cause symptoms. It could be taken with or without food.

Effervescent forms: Tablets and granules had to be dissolved in water before they were swallowed.

Liquid forms: The syrup was measured using a specific dose-measuring device rather than a regular spoon.

Missed Dose

If a dose was missed, the general advice was to take it as soon as it was remembered. If it was almost time for the next scheduled dose, the missed dose was skipped. It was not recommended to take a double dose to make up for a missed one.

Current Market Status

The FDA has requested that all ranitidine products be removed from the market due to safety concerns. Individuals should stop taking any remaining ranitidine and consult a healthcare provider for alternative treatments.

Question 9

Is Ranitidine safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Ranitidine is generally considered to have no known risk of causing birth defects or other developmental issues in humans based on limited data. Animal reproduction studies using doses significantly higher than human doses have not shown evidence of impaired fertility or harm to the fetus. However, there are no adequate and well-controlled studies in pregnant women. Because animal studies are not always predictive of human response, ranitidine should be used during pregnancy only if a healthcare provider determines it is clearly necessary.

Breastfeeding

Ranitidine is excreted in human breast milk. The clinical significance of this exposure to a nursing infant is not fully understood. Caution should be exercised when ranitidine is administered to someone who is breastfeeding. It is important to discuss the potential risks and benefits with a healthcare professional before using this medication while nursing.

Market Status and Safety

In 2020, the FDA requested the removal of all ranitidine products from the U.S. market due to concerns about N-Nitrosodimethylamine (NDMA) contamination. NDMA is a substance that could potentially cause cancer. Individuals who are pregnant or breastfeeding and were previously using ranitidine should consult their healthcare provider for information on alternative treatments that are currently available and approved for use.

Question 10

What forms and strengths does Ranitidine come in?

Accepted Answer

Available Forms Before Market Removal

Before its removal from the market, ranitidine was available in the following forms:

Oral tablets

Oral capsules

Effervescent tablets

Effervescent granules

Oral syrup (liquid)

Injectable solution

Current Market Status

The U.S. Food and Drug Administration (FDA) requested the removal of all prescription and over-the-counter ranitidine products from the market. This action was taken after testing found a contaminant that could increase over time and when stored at higher temperatures. As a result, these forms are no longer available for use.

Question 11

What is the FDA approval status of Ranitidine?

Accepted Answer

Market Withdrawal

In April 2020, the U.S. Food and Drug Administration (FDA) requested that manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine medications from the market. This regulatory action was taken because of the presence of N-Nitrosodimethylamine (NDMA), an impurity classified as a probable human carcinogen, in some ranitidine products.

Safety Findings

FDA investigations determined that NDMA levels in ranitidine can increase over time, especially when the medication is stored at temperatures higher than room temperature. Testing showed that the older a ranitidine product is, or the longer it has been since it was manufactured, the higher the level of NDMA may be. These levels could potentially exceed acceptable daily intake limits, leading the FDA to conclude that the drug should no longer be available to consumers.

Current Status and Alternatives

Ranitidine is currently not available for sale in the United States. The FDA advised patients to stop taking any ranitidine they had and to consult with healthcare professionals about alternative treatments. Other acid-reducing medications, such as famotidine, cimetidine, and omeprazole, have not been found to contain NDMA and remain available for use. Some products previously sold under brand names associated with ranitidine have been reformulated with different active ingredients that do not carry the same risks.

Question 12

What should I know about Ranitidine and recall?

Accepted Answer

Reason for the Recall

The market withdrawal was prompted by the discovery of a contaminant called N-Nitrosodimethylamine (NDMA) in ranitidine medications. NDMA is classified as a probable human carcinogen, which is a substance that could potentially cause cancer in humans.

Contamination Risks

FDA testing revealed that the levels of NDMA in ranitidine can increase over time, even when the medication is stored under normal conditions. Furthermore, NDMA levels were found to increase significantly when the drug was exposed to higher temperatures. Because the FDA could not guarantee that NDMA levels would remain within safe limits throughout the shelf life of the product, all versions of the drug were removed from the market.

Guidance for Patients

If you have ranitidine in your possession, you should follow these safety steps:

Stop taking the medication: Do not use any remaining ranitidine tablets, capsules, or liquids.

Dispose of the drug properly: Follow the disposal instructions on the product label or consult a pharmacist for guidance on how to safely discard the medication.

Seek alternatives: Consult a healthcare provider to discuss other treatment options for acid reflux, heartburn, or ulcers. There are several other medications available that do not carry the same NDMA risks.

It is important to note that while some products with similar brand names have returned to store shelves, they have been reformulated with different active ingredients that were not part of this recall.

Ranitidine

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Recall Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?